Helen M. Thackray Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Helen M. Thackray.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Helen M. Thackray. Helen M. Thackray is Chief R&D Officer in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and SVP Clinical Development, CMO in GLYCOMIMETICS INC ($GLYC) and VP Clinical Development, CMO in GLYCOMIMETICS INC ($GLYC).

Helen M. Thackray in BIOCRYST PHARMACEUTICALS INC

Trading Symbol: BCRX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Helen M. Thackray: Chief R&D Officer, Director
Holdings: 100,000 shares
Current Value: $567,000
Latest Transaction: Apr 02 2021
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Helen M. Thackray in BIOCRYST PHARMACEUTICALS INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BCRX, GLYC

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Apr 02 2021	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Chief R&D Officer	Option Exercise	A	10.17	400,000	4,068,000	400,000
Apr 02 2021	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Chief R&D Officer	Grant	A	0.00	100,000	0	100,000	0 to 100 K
May 14 2020	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Director	Option Exercise	A	5.41	40,000	216,400	40,000
Sep 24 2019	BCRX	BIOCRYST PHARMACEU ...	Thackray Helen M.	Director	Option Exercise	A	2.86	40,000	114,400	40,000

Page: 1